Annual Drug Patent Expirations for VICTOZA Victoza is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from two suppliers. There are seven…
The post New patent expiration for Novo Nordisk drug VICTOZA appeared first on Dr…
New patent expiration for Novo Nordisk drug VICTOZA Read Post »
VICTOZA (liraglutide recombinant) Novo nordisk inc Patent: 8,846,618 Expiration: Dec 27, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Patent Expiration…
Drug Patent Expirations for the Week of December 25, 2022 Read Post »
Annual Drug Patent Expirations for SAXENDA Saxenda is a drug marketed by Novo and is included in one NDA. It is available from two suppliers. There are twenty-five patents protecting…
The post New patent expiration for NOVO drug SAXENDA appeared first …
Annual Drug Patent Expirations for ANJESO Anjeso is a drug marketed by Baudax and is included in one NDA. There are eight patents protecting this drug. Drug patent litigation for…
The post New patent expiration for Baudax drug ANJESO appeared first on …
Annual Drug Patent Expirations for RYANODEX Ryanodex is a drug marketed by Eagle Pharms and is included in one NDA. It is available from one supplier. There are five patents…
The post New patent expiration for Eagle Pharms drug RYANODEX appeared first …
New patent expiration for Eagle Pharms drug RYANODEX Read Post »
Annual Drug Patent Expirations for RYANODEX Ryanodex is a drug marketed by Eagle Pharms and is included in one NDA. It is available from one supplier. There are five patents…
The post New patent expiration for Eagle Pharms drug RYANODEX appeared first …
New patent expiration for Eagle Pharms drug RYANODEX Read Post »
Annual Drug Patent Expirations for EPIDUO+FORTE Epiduo Forte is a drug marketed by Galderma Labs and is included in one NDA. It is available from three suppliers. There are nine…
The post New patent expiration for Galderma Labs drug EPIDUO FORTE appear…
New patent expiration for Galderma Labs drug EPIDUO FORTE Read Post »
Annual Drug Patent Expirations for EPIDUO Epiduo is a drug marketed by Galderma Labs Lp and Galderma Labs and is included in two NDAs. It is available from two suppliers.…
The post New patent expiration for Galderma Labs drug EPIDUO appeared first on D…
New patent expiration for Galderma Labs drug EPIDUO Read Post »
Annual Drug Patent Expirations for EPIDUO Epiduo is a drug marketed by Galderma Labs Lp and Galderma Labs and is included in two NDAs. It is available from two suppliers.…
The post New patent expiration for Galderma Labs drug EPIDUO appeared first on D…
New patent expiration for Galderma Labs drug EPIDUO Read Post »
Annual Drug Patent Expirations for OFORTA Oforta is a drug marketed by Sanofi Aventis Us and is included in one NDA. There is one patent protecting this drug. This drug…
The post New patent expiration for Sanofi Aventis drug OFORTA appeared first on Dr…
New patent expiration for Sanofi Aventis drug OFORTA Read Post »